Benefits of ERCPs outweigh superbug risks, FDA says

Modern Healthcare (complimentary online subscription): The U.S. Food and Drug Administration Wednesday advised health providers not to cancel surgical procedures involving the use of the medical endoscopes. Endoscopes have been linked to drug-resistant superbug outbreaks at two California hospitals in recent months, but the FDA said the benefits of performing such procedures still outweigh the potential risks.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending